Schroder Investment Management Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-944,880
Closed -$2.03M 1242
2023
Q2
$2.03M Buy
944,880
+42,095
+5% +$102K ﹤0.01% 943
2023
Q1
$2.63M Buy
902,785
+26,317
+3% +$133K ﹤0.01% 904
2022
Q4
$6.02M Buy
876,468
+138,595
+19% +$654K 0.01% 746
2022
Q3
$2.35M Sell
737,873
-988,975
-57% -$3.59M ﹤0.01% 916
2022
Q2
$5.94M Sell
1,726,848
-85,237
-5% -$247K 0.01% 758
2022
Q1
$5.54M Sell
1,812,085
-30,839
-2% -$104K 0.01% 812
2021
Q4
$8.22M Buy
1,842,924
+79,961
+5% +$392K 0.01% 645
2021
Q3
$11.6M Buy
1,762,963
+952,291
+117% +$9.13M 0.02% 601
2021
Q2
$13M Buy
+810,672
New +$11.2M 0.02% 608
2018
Q3
Sell
-164,369
Closed -$4.37M 1334
2018
Q2
$4.37M Buy
+164,369
New +$4.47M 0.01% 738

Other funds holding STIM

Schroder Investment Management Group's STIM Position: Q3 2023 in Review

Schroder Investment Management Group sold out of Neuronetics (STIM) in Q3 2023, closing a stake of 944,880 shares — an estimated $2.03M sold.

Schroder Investment Management Group first reported a position in STIM in Q2 2018 and held it in 10 quarters. The position peaked at $13M in Q2 2021. 56 funds tracked by Wall St. Rank hold STIM as of Q3 2023.

  • Schroder Investment Management Group reported no remaining Neuronetics position as of Q3 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 944,880 Neuronetics shares in Q3 2023, an estimated $2.03M.
  • Schroder Investment Management Group first reported a position in Neuronetics in Q2 2018 and held it in 10 quarters.
  • Schroder Investment Management Group's Neuronetics position peaked at $13M in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Neuronetics as of Q3 2023.

Based on Schroder Investment Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.